Histopathological and patient-related characteristics of basal cell carcinomas of the head and neck influencing therapeutic management
- PMID: 30603060
- PMCID: PMC6291759
- DOI: 10.4081/dr.2018.7674
Histopathological and patient-related characteristics of basal cell carcinomas of the head and neck influencing therapeutic management
Abstract
The authors hypothesize that histopathological characteristics of basal cell carcinomas of the head and neck (BCCHN) have changed over time and the correlation of BCCHN localization and histological tumour type can help improving the number and quality of necessary therapeutic interventions. Information of 222 patients with 344 BCCHN was gained. Descriptive measures were compared to prior studies to prove whether or not characteristics of basal cell carcinomas or patients have changed over time. Afterwards descriptive measures were correlated with number of conducted operations to evaluate if tumour localization, histological tumour type and number of operations depend on one another. Aggravating factors which lead to a higher number of operations were older age, greater size of BCCHN, adjacent elastosis, the localizations eye, ear and nose and histological tumour types morpheaform and nodularulcerated. In comparison to earlier studies characteristics of BCCHN and patients showed positive developments because of grown awareness of BCCHN. Furthermore, our correlations demonstrate that therapeutic results of BCCHN treatment are continuously improving. Nevertheless, treatment of aggressive morpheaform BCCHN in combination with distinctive patient characteristics still needs improvement.
Keywords: Basal cell carcinoma; Head; Histopathological characteristics; Neck; Patientrelated characteristics.
Conflict of interest statement
Conflict of interest: the authors declare no potential conflict of interest.
Similar articles
-
Trends of basal cell carcinoma at the Centre of Dermatovenereology of Vilnius University.Acta Med Litu. 2018;25(4):197-205. doi: 10.6001/actamedica.v25i4.3930. Acta Med Litu. 2018. PMID: 31308825 Free PMC article.
-
The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.Dan Med Bull. 1998 Apr;45(2):121-34. Dan Med Bull. 1998. PMID: 9587699 Review.
-
Surgical treatment and dilemmas in the treatment of basal cell carcinomas with intracranial propagation.Vojnosanit Pregl. 2014 Nov;71(11):1045-8. doi: 10.2298/vsp1411045r. Vojnosanit Pregl. 2014. PMID: 25536808
-
Comparative Analyses of Tumour Volume Doubling Times for Periocular and Non-periocular Head and Neck Basal Cell Carcinomas.Acta Derm Venereol. 2019 Dec 1;99(13):1266-1269. doi: 10.2340/00015555-3325. Acta Derm Venereol. 2019. PMID: 31573662
-
Morpheaform basal cell carcinoma in African Americans.Dermatol Surg. 2004 Dec;30(12 Pt 2):1550-2. doi: 10.1111/j.1524-4725.2004.30558.x. Dermatol Surg. 2004. PMID: 15606838 Review.
Cited by
-
Analysis of the occurrence and distribution of primary and recurrent basal cell carcinoma of head and neck coupled to the assessment of tumor microenvironment and Sonic hedgehog signaling.Rom J Morphol Embryol. 2020 Jul-Sep;61(3):821-831. doi: 10.47162/RJME.61.3.20. Rom J Morphol Embryol. 2020. PMID: 33817723 Free PMC article.
-
Factors Influencing Margin Clearance and the Number of Stages of Mohs Micrographic Surgery in Basal Cell Carcinoma: A Retrospective Chart Review.Cancers (Basel). 2024 Jun 28;16(13):2380. doi: 10.3390/cancers16132380. Cancers (Basel). 2024. PMID: 39001442 Free PMC article.
-
Comparison of Demographic and Clinicopathological Characteristics of Basal Cell Carcinoma on the Nose and Other Sites of the Face: A Cross-Sectional Study.Iran J Otorhinolaryngol. 2021 Sep;33(118):257-262. doi: 10.22038/ijorl.2021.47720.2575. Iran J Otorhinolaryngol. 2021. PMID: 34692572 Free PMC article.
References
-
- Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012;166:1069-80. - PubMed
-
- Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 995;131:157-63. - PubMed
-
- Youssef KK, Van Keymeulen A, Lapouge G, et al. Identification of the cell lineage at the origin of basal cell carcinoma. Nature Cell Biol 2010;12:299-305. - PubMed
-
- Vantuchova Y, Curik R. Histological types of basal cell carcinoma. Scripta Medica (Brno) 2006;79:261-70.
LinkOut - more resources
Full Text Sources